Geron GERN
$0.87 −$0.04 (-4.63%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $0.89 +2.45%
Open$0.89
Prev close$0.91
Day range$0.86 – $0.93
Volume13.83M
Market cap$560.94M
P/E (TTM)–
Dividend yield–
GERN Stock News
Headlines matching Geron or the GERN ticker, most recent first.
- H.C. Wainwright Maintains Geron(GERN.US) With Hold Rating
- Needham Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $4
- TD Cowen Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $3
- Earnings Flash (GERN) Geron Corporation Reports Q2 Revenue $57.5M, Vs. FactSet Est of $55.3M
- 4: Geron | 4: Statement of changes in beneficial ownership of securities-Director Spiegel Robert J.
- Geron | 4: Statement of changes in beneficial ownership of securities-Director O'Farrell Elizabeth G.
- Geron | 4: Statement of changes in beneficial ownership of securities-Director Spiegel Robert J.
- Analysts Offer Insights on Healthcare Companies: BioAge Labs, Inc. (BIOA) and Geron (GERN)
- Geron | 4: Statement of changes in beneficial ownership of securities-Director Spiegel Robert J.
- A Quick Look at Today's Ratings for Geron(GERN.US), With a Forecast Between $1 to $4
- Goldman Sachs Maintains Geron(GERN.US) With Sell Rating, Maintains Target Price $1
- Stifel Maintains Geron(GERN.US) With Buy Rating, Cuts Target Price to $3.5 Negative
- Wedbush Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $5
- Wedbush Maintains Geron(GERN.US) With Buy Rating, Cuts Target Price to $5 Negative
- TD Cowen Maintains Geron(GERN.US) With Buy Rating, Maintains Target Price $3
No comments yet — be the first to weigh in on GERN.
Sign in to join the discussion.